Renol Polychem Stock Price Today (NSE: RNPL)

Renol Polychem

52.602.75 (4.97%)
Market Closed

Fundamental Score

...

Renol Polychem Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Renol Polychem share price today is 52.60, down 4.97% on NSE/BSE as of 22 September 2026. Renol Polychem (RNPL) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of 92.56 (Cr). The 52-week high for RNPL share price is 156.00 and the 52-week low is 52.60. At a P/E ratio of 11.22x, RNPL is currently trading below its industry average P/E of 31.95x. The company has a Return on Equity (ROE) of 13.56% and a debt-to-equity ratio of 0.16.

Renol Polychem Share Price Chart — NSE/BSE Historical Performance

No data
High
85.50
Low
52.60
Volume
7.1K
Change
-14.93%

Renol Polychem share price chart: -14.93% return over the past month. 52-week high ₹156.00, 52-week low ₹52.60.

Renol Polychem — Last 10 Trading Days

DateOpenHighLowCloseVolume
57.9057.9052.6052.6022.80K (Cr)
55.3555.3555.3555.357.20K (Cr)
58.0558.2558.0558.254.80K (Cr)
58.0058.0055.1055.5015.60K (Cr)
57.5558.0057.5558.008.40K (Cr)
60.0060.5560.0060.554.80K (Cr)
61.8562.0061.8561.8514.40K (Cr)
65.1065.1065.1065.1012.00K (Cr)
70.2070.8568.5068.5025.20K (Cr)
75.9075.9072.1072.103.60K (Cr)

Renol Polychem — Last 12 Months Price History

MonthOpenHighLowCloseChange
80.0083.0052.6052.60-34.25%
84.8086.5072.2078.25-7.72%
83.5085.9572.5582.00-1.80%
75.3575.3575.3575.35+0.00%
141.00141.0087.8087.80-37.73%
134.00139.00134.00138.75+3.54%
141.70141.70134.05135.00-4.73%
151.20151.95145.00145.00-4.10%
146.90151.95139.00150.00+2.11%
149.95156.00140.00141.00-5.97%
130.65146.20119.00145.05+11.02%
77.0082.9070.1075.00-2.60%

Returns & Performance

Poor

Return on Equity (ROE)

13.56%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

14.50%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Renol Polychem Valuation Check

Excellent

Price to Earnings (P/E)

11.22x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

31.95x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

51.10%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

109.64%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

49.28%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.16x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

39.52x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Renol Polychem Fundamental Analysis & Valuation Benchmarking

Educational evaluation of RNPL across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Attractive Valuation (P/E: 11.22 vs Industry: 31.95)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (109.64%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (49.28%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Conservative Debt Levels (D/E: 0.16)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (39.52x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (51.10%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

1 factors identified

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Renol Polychem vs Specialty Chemicals Peers

Peer Comparison - Specialty Chemicals

Compare Renol Polychem with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
30/100
53
₹92.56
11.2
Average
13.56%
Average
14.50%
Average
0.2
Excellent
0.00%
65.3/100
1572
₹159998.16
60.4
Average
23.79%
Excellent
29.92%
Excellent
0.0
Excellent
16.70%
Excellent
14.89%
Good
0.73%
42.9/100
4755
₹52305.00
85.4
Average
7.65%
Poor
10.87%
Average
0.3
Excellent
36.34%
Excellent
13.52%
Good
0.07%
62.7/100
8776
₹45018.32
56.9
Average
20.11%
Excellent
21.48%
Excellent
0.3
Excellent
20.84%
Excellent
22.95%
Excellent
0.20%
32.8/100
1641
₹22385.97
28.6
Average
9.81%
Poor
11.31%
Average
0.3
Excellent
-6.63%
Poor
12.59%
Good
0.44%
36.3/100
1616
₹21439.79
90.9
Average
9.38%
Poor
12.78%
Average
0.2
Excellent
0.00%
58.2/100
6240
₹18370.56
23.1
Average
11.47%
Average
14.24%
Average
0.0
Excellent
54.89%
Excellent
10.95%
Good
0.49%
38.7/100
497
₹18009.05
33.9
Average
7.25%
Poor
8.86%
Poor
0.8
Good
-4.35%
Poor
12.96%
Good
0.20%
52.2/100
3749
₹16227.26
25.2
Average
0.00%
Poor
14.04%
Average
0.0
Excellent
7.67%
Good
9.35%
Good
0.68%
62.09999999999999/100
5170
₹15849.69
36.2
Average
16.82%
Good
21.91%
Excellent
0.0
Excellent
28.23%
Excellent
15.86%
Excellent
0.21%
33.3/100
1228
₹13980.53
79.8
Average
5.50%
Poor
9.10%
Poor
0.5
Good
19.33%
Excellent
23.88%
Excellent
0.06%

Renol Polychem Quarterly Performance

Latest quarterly metrics for RNPL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

49.28%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

109.64%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Renol Polychem Technical Indicators

SMA 50, SMA 200, RSI and volume signals for RNPL — calculated from daily price history

34RSI 14
Neutral — RSI 34

Momentum is balanced — neither overbought nor oversold.

SMA 50
95
▼ Price below SMA 50 — Short-term bearish
30-Day Avg Volume
7K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Renol Polychem Financial Statements

Annual income statement, balance sheet and cash flow for Renol Polychem (RNPL) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Renol Polychem

Loading latest quarterly results...

About RNPL (Renol Polychem)

Renol Polychem (RNPL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Specialty Chemicals sector with a current... market capitalisation of ₹92.56 (Cr). Renol Polychem has delivered a Return on Equity (ROE) of 13.56% and a ROCE of 14.50%. The debt-to-equity ratio stands at 0.16, reflecting the company's capital structure. Investors tracking RNPL share price can monitor key metrics including P/E ratio, promoter holding of 51.10%, and quarterly earnings growth.

Company Details

Symbol:RNPL
Industry:Specialty Chemicals
Sector:Specialty Chemicals
Website:N/A

RNPL Share Price: Frequently Asked Questions

What is the current share price of Renol Polychem?

Renol Polychem (RNPL) trades at ₹52.60 on NSE. Market cap ₹92.56 (Cr). Educational data only.

What is the P/E ratio of Renol Polychem?

Renol Polychem has a P/E of 11.22x vs industry average 31.95x.

What is the Bull Run score for Renol Polychem?

Renol Polychem has a Bull Run score of 30/100 based on 25+ financial parameters.

Does Renol Polychem pay dividends?

Renol Polychem has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Renol Polychem?

Renol Polychem has ROE of 13.56%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Renol Polychem?

Renol Polychem has debt-to-equity of 0.16.

Is Renol Polychem a good investment?

Bull Run gives Renol Polychem a score of 30/100. This is not investment advice — consult a SEBI-registered advisor.